Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on Toll-like receptor 4
Authors
Keywords
-
Journal
ARTHRITIS AND RHEUMATISM
Volume 64, Issue 5, Pages 1477-1487
Publisher
Wiley
Online
2011-12-01
DOI
10.1002/art.33495
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transamidation by Transglutaminase 2 Transforms S100A11 Calgranulin into a Procatabolic Cytokine for Chondrocytes
- (2014) D. L. Cecil et al. JOURNAL OF IMMUNOLOGY
- Active involvement of alarmins S100A8 and S100A9 in the regulation of synovial activation and joint destruction during mouse and human osteoarthritis
- (2011) Peter L. E. M. van Lent et al. ARTHRITIS AND RHEUMATISM
- Osteoarthritis year 2010 in review: pathomechanisms
- (2011) W.B. van den Berg OSTEOARTHRITIS AND CARTILAGE
- S100A8 causes a shift toward expression of activatory Fcγ receptors on macrophages via toll-like receptor 4 and regulates Fcγ receptor expression in synovium during chronic experimental arthritis
- (2010) Peter L. van Lent et al. ARTHRITIS AND RHEUMATISM
- The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis
- (2010) Jan Bondeson et al. ARTHRITIS AND RHEUMATISM
- Targeting the synovial tissue for treating osteoarthritis (OA): where is the evidence?
- (2010) Mukundan Attur et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Sumoylation and Nuclear Translocation of S100A4 Regulate IL-1β-mediated Production of Matrix Metalloproteinase-13
- (2010) Keally J. Miranda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis
- (2010) Jérémie Sellam et al. Nature Reviews Rheumatology
- Role of proinflammatory cytokines in the pathophysiology of osteoarthritis
- (2010) Mohit Kapoor et al. Nature Reviews Rheumatology
- S100A8 and S100A9 in experimental osteoarthritis
- (2010) Hala Zreiqat et al. ARTHRITIS RESEARCH & THERAPY
- The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer
- (2009) Jan M. Ehrchen et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Developments in the scientific understanding of osteoarthritis
- (2009) Steven B Abramson et al. ARTHRITIS RESEARCH & THERAPY
- Differential Toll-like receptor-dependent collagenase expression in chondrocytes
- (2008) Q Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis
- (2008) H B. Hammer et al. ANNALS OF THE RHEUMATIC DISEASES
- Stimulation of chondrocyte-mediated cartilage destruction by S100A8 in experimental murine arthritis
- (2008) P. L. E. M. van Lent et al. ARTHRITIS AND RHEUMATISM
- Cartilage in normal and osteoarthritis conditions
- (2008) Johanne Martel-Pelletier et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
- (2008) Olga Turovskaya et al. CARCINOGENESIS
- S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products
- (2008) John H. Boyd et al. CIRCULATION RESEARCH
- S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway
- (2008) S. Ghavami et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis
- (2007) P L E M van Lent et al. ANNALS OF THE RHEUMATIC DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started